About ResMed Inc. (RMD)
ResMed Inc. is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in San Diego, United States. RMD has been publicly traded since 1999, giving it 27+ years of trading history.
ResMed Inc. (RMD) has been publicly traded since 1999, making it a 27-year-old public company. It operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company is headquartered in San Diego, United States. With a market capitalization of A$48 billion, RMD is a large established company.
RMD trades on the Australian Securities Exchange and is classified as a large-cap-cap stock with a market capitalization of approximately A$48 billion.
Key Statistics
- Current Price
- A$32.97
- Market Cap
- A$48.03B
- 52-Week High
- A$45.25
- 52-Week Low
- A$32.04
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
RMD Investment Performance
RMD has declined 8.1% year-to-date in 2026. Over the past 5 years, a A$1,000 investment in RMD would have grown to A$1,345, representing a 34.5% total return. Since its IPO in 1999, a A$1,000 investment would now be worth A$44,480.
A$1,000 Invested in ResMed Inc. (RMD)
How much would A$1,000 invested in RMD be worth today?
What would A$1,000 invested in RMD 1 year ago be worth today?
A A$1,000 investment in ResMed Inc. (RMD) in 2025 would be worth A$949 as of March 2026, representing a -5.1% total return.
What would A$1,000 invested in RMD 3 years ago be worth today?
A A$1,000 investment in ResMed Inc. (RMD) in 2023 would be worth A$1,037 as of March 2026, representing a +3.7% total return.
What would A$1,000 invested in RMD 5 years ago be worth today?
A A$1,000 investment in ResMed Inc. (RMD) in 2021 would be worth A$1,345 as of March 2026, representing a +34.5% total return.
What would A$1,000 invested in RMD 10 years ago be worth today?
A A$1,000 investment in ResMed Inc. (RMD) in 2016 would be worth A$4,696 as of March 2026, representing a +369.6% total return.
What would A$1,000 invested in RMD at IPO be worth today?
A A$1,000 investment in ResMed Inc. (RMD) at IPO would be worth A$44,480 as of March 2026, representing a +4348.0% total return.
Monthly Returns Heatmap
Over the past 26+ years (316 months), ResMed Inc. (RMD) has averaged a monthly return of +1.59% with a median return of +1.19%. The stock had 184 positive months (58%) and 132 negative months (42%). The best month in RMD's history was February 2000 with a +61.2% return, while the worst was May 2002 at -29.4%. Historically, November tends to be the strongest month (averaging +3.8%), and September the weakest (-0.7%).
RMD's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2000 with a cumulative return of +102.3%, and the worst was 2002 at -53.5%.
Annual Returns
Over 27 years of trading history, ResMed Inc. (RMD) has delivered an average annual return of +19.30% with a median return of +17.71%. The compound annual growth rate (CAGR) is +14.87%. The stock posted gains in 19 years (70%) and losses in 8 years (30%).
RMD's best year was 2000 with a +111.42% gain, while the worst was 2002 at -48.13%. The longest streak of consecutive positive years was 10, and the longest losing streak was 2 years. RMD achieved double-digit gains (10%+) in 17 years. It suffered double-digit losses in 4 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -8.12% | A$35.88 | A$32.97 |
| 2025 | -1.69% | A$36.50 | A$35.88 |
| 2024 | +45.43% | A$25.10 | A$36.50 |
| 2023 | -17.30% | A$30.35 | A$25.10 |
| 2022 | -13.00% | A$34.89 | A$30.35 |
| 2021 | +32.11% | A$26.41 | A$34.89 |
| 2020 | +24.88% | A$21.15 | A$26.41 |
| 2019 | +38.09% | A$15.31 | A$21.15 |
| 2018 | +45.69% | A$10.51 | A$15.31 |
| 2017 | +29.57% | A$8.11 | A$10.51 |
| 2016 | +15.32% | A$7.03 | A$8.11 |
| 2015 | +8.08% | A$6.51 | A$7.03 |
| 2014 | +33.57% | A$4.87 | A$6.51 |
| 2013 | +36.50% | A$3.57 | A$4.87 |
| 2012 | +60.71% | A$2.22 | A$3.57 |
| 2011 | -29.23% | A$3.14 | A$2.22 |
| 2010 | +17.71% | A$2.67 | A$3.14 |
| 2009 | +10.63% | A$2.41 | A$2.67 |
| 2008 | -9.92% | A$2.68 | A$2.41 |
| 2007 | -6.00% | A$2.85 | A$2.68 |
| 2006 | +20.57% | A$2.36 | A$2.85 |
| 2005 | +62.29% | A$1.45 | A$2.36 |
| 2004 | +14.31% | A$1.27 | A$1.45 |
| 2003 | +4.43% | A$1.22 | A$1.27 |
| 2002 | -48.13% | A$2.35 | A$1.22 |
| 2001 | +43.27% | A$1.64 | A$2.35 |
| 2000 | +111.42% | A$0.78 | A$1.64 |
RMD Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating ResMed Inc. as an investment
Valuation
RMD currently trades at a trailing P/E ratio of 23.2, which is considered moderate relative to the broader market. The forward P/E of 18.5 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 0.5. The price-to-sales ratio is 8.9.
Dividends
ResMed Inc. pays a dividend to shareholders with a current yield of 1.05%. This translates to A$0.35 per share annually. The payout ratio of 22% indicates sustainable dividend coverage.
Risk & Volatility
RMD has a beta of 0.89, indicating it is similarly volatile to the overall market. The stock's 52-week range is A$32.04 to A$45.25, and it currently trades near its 52-week low.
Analyst Ratings
Based on 12 analyst opinions, RMD has a consensus "strong_buy" rating. The average price target of A$46.94 suggests 42.4% upside from current levels.
Frequently Asked Questions: RMD
What sector is RMD in? ▼
RMD operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has RMD performed historically? ▼
Over 27 years of trading history, RMD has posted gains in 19 years (70% of the time). The best year was 2000 with a +111.4% return. Past performance does not guarantee future results.
How can I invest in RMD? ▼
You can invest in RMD through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold RMD.
Does RMD pay dividends? ▼
ResMed Inc. pays a dividend to shareholders with a current yield of 1.05%. This translates to A$0.35 per share annually. The payout ratio of 22% indicates sustainable dividend coverage.
What does ResMed Inc. do? ▼
ResMed Inc. is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in San Diego, United States.
What sector is RMD in? ▼
RMD operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
When did RMD go public? ▼
ResMed Inc. went public in 1999, making it a 27-year-old public company as of 2026.
How much would A$1,000 invested in RMD 5 years ago be worth today? ▼
A A$1,000 investment in RMD five years ago would be worth approximately A$1,345 today, representing a 34.5% return.
How much would A$1,000 invested in RMD 10 years ago be worth today? ▼
A A$1,000 investment in RMD ten years ago would be worth approximately A$4,696 today, representing a 369.6% total return over the decade.
What is RMD's 3-year return? ▼
Over the past 3 years, RMD has returned 3.7%. A A$1,000 investment would have grown to A$1,037.
How much would A$1,000 invested in RMD at IPO be worth today? ▼
If you invested A$1,000 in RMD at its IPO in 1999, it would be worth approximately A$44,480 today, a 4,348.0% return over 27 years.
Does RMD pay dividends? ▼
Yes, ResMed Inc. pays a dividend with a current yield of 1.05%, which is A$0.35 per share annually.
What is RMD's market cap? ▼
ResMed Inc. has a market capitalization of A$48 billion, classifying it as a large-cap company.
What is RMD's P/E ratio? ▼
RMD has a trailing P/E ratio of 23.2 and a forward P/E of 18.5, which measures how much investors are paying per dollar of earnings.
Is RMD a buy, hold, or sell? ▼
Based on 12 opinions, RMD has a consensus "strong_buy" rating. The average price target is A$46.94.
Last updated: 3/15/2026